Citation: Pl. Boyer et al., A MUTATION AT POSITION 190 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE INTERACTS WITH MUTATIONS AT POSITION-74 AND POSITION-75 VIA THE TEMPLATE PRIMER, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 447-452
Authors:
NISSLEY DV
BOYER PL
GARFINKEL DJ
HUGHES SH
STRATHERN JN
Citation: Dv. Nissley et al., HYBRID TY1 HIV-1 ELEMENTS USED TO DETECT INHIBITORS AND MONITOR THE ACTIVITY OF HIV-1 REVERSE-TRANSCRIPTASE/, Proceedings of the National Academy of Sciences of the United Statesof America, 95(23), 1998, pp. 13905-13910
Citation: Hq. Gao et al., EFFECTS OF MUTATIONS IN THE POLYMERASE DOMAIN ON THE POLYMERASE, RNASE-H AND STRAND TRANSFER ACTIVITIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE, Journal of Molecular Biology, 277(3), 1998, pp. 559-572
Authors:
SMITH MBK
MICHEJDA CJ
HUGHES SH
BOYER PL
JANSSEN PAJ
ANDRIES K
BUCKHEIT RW
SMITH RH
Citation: Mbk. Smith et al., MOLECULAR MODELING OF HIV-1 REVERSE-TRANSCRIPTASE DRUG-RESISTANT MUTANT STRAINS - IMPLICATIONS FOR THE MECHANISM OF POLYMERASE ACTION, Protein engineering, 10(12), 1997, pp. 1379-1383
Authors:
LOYA S
GAO HQ
AVIDAN O
BOYER PL
HUGHES SH
HIZI A
Citation: S. Loya et al., SUBUNIT-SPECIFIC MUTAGENESIS OF THE CYSTEINE-280 RESIDUE OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 - EFFECTS ON SENSITIVITY TO A SPECIFIC INHIBITOR OF THE RNASE-H ACTIVITY, Journal of virology, 71(7), 1997, pp. 5668-5672
Authors:
ROTH T
MORNINGSTAR ML
BOYER PL
HUGHES SH
BUCKHEIT RW
MICHEJDA CJ
Citation: T. Roth et al., SYNTHESIS AND BIOLOGICAL-ACTIVITY OF NOVEL NONNUCLEOSIDE INHIBITORS OF HIV-1 REVERSE-TRANSCRIPTASE - 2-ARYL-SUBSTITUTED BENZIMIDAZOLES, Journal of medicinal chemistry, 40(26), 1997, pp. 4199-4207
Citation: Pl. Boyer et Sh. Hughes, NUCLEOSIDE-ANALOG RESISTANCE INVOLVES THE P66 SUBUNIT OF HIV-1 RT, Nature structural biology, 3(7), 1996, pp. 579-580
Authors:
DAS K
DING JP
HSIOU Y
CLARK AD
MOEREELS H
KOYMANS L
ANDRIES K
PAUWELS R
JANSSEN PAJ
BOYER PL
CLARK P
SMITH RH
SMITH MBK
MICHEJDA CJ
HUGHES SH
ARNOLD E
Citation: K. Das et al., CRYSTAL-STRUCTURES OF 8-CL AND 9-CL TIBO COMPLEXED WITH WILD-TYPE HIV-1 RT AND 8-CL TIBO COMPLEXED WITH THE TYR181CYS HIV-1 RT DRUG-RESISTANT MUTANT, Journal of Molecular Biology, 264(5), 1996, pp. 1085-1100
Authors:
BOYER PL
TANTILLO C
DING J
FERRIS AL
CLARK P
ARNOLD E
HUGHES SH
Citation: Pl. Boyer et al., MECHANISMS OF RESISTANCE OF HIV-1 REVERSE-TRANSCRIPTASE TO NUCLEOSIDEAND NONNUCLEOSIDE INHIBITORS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 6-6
Authors:
ARNOLD E
DAS K
DING JP
HSIOU Y
TANTILLO C
ROY BM
YADAV P
ZHANG WY
LENTZ K
CLARK AD
BOYER PL
HUGHES SH
MITSUYA H
MELLORS J
KLEIM JP
ROSNER M
MOEREELS HR
KOYMANS L
ANDRIES K
PAUWELS R
JANSSEN PAJ
Citation: E. Arnold et al., THE ROLE OF NUCLEIC-ACID IN THE RESISTANCE OF HIV-1 REVERSE-TRANSCRIPTASE TO NUCLEOSIDE AND NONNUCLEOSIDE INHIBITORS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 7-7
Authors:
SMITH MBK
ROUZER CA
TANEYHILL LA
SMITH NA
HUGHES SH
BOYER PL
JANSSEN PAJ
MOEREELS H
KOYMANS L
ARNOLD E
DING JP
DAS K
ZHANG WY
MICHEJDA CJ
SMITH RH
Citation: Mbk. Smith et al., MOLECULAR MODELING STUDIES OF HIV-1 REVERSE-TRANSCRIPTASE NONNUCLEOSIDE INHIBITORS - TOTAL-ENERGY OF COMPLEXATION AS A PREDICTOR OF DRUG PLACEMENT AND ACTIVITY, Protein science, 4(10), 1995, pp. 2203-2222
Citation: Pl. Boyer et Sh. Hughes, ANALYSIS OF MUTATIONS AT POSITION-184 IN REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Antimicrobial agents and chemotherapy, 39(7), 1995, pp. 1624-1628
Authors:
BUCKHEIT RW
FLIAKASBOLTZ V
YEAGYBARGO S
WEISLOW O
MAYERS DL
BOYER PL
HUGHES SH
PAN BC
CHU SH
BADER JP
Citation: Rw. Buckheit et al., RESISTANCE TO 1-[(2-HYDROXYETHOXY)METHYL]-6-(PHENYLTHIO)THYMINE DERIVATIVES IS GENERATED BY MUTATIONS AT MULTIPLE SITES IN THE HIV-1 REVERSE-TRANSCRIPTASE, Virology, 210(1), 1995, pp. 186-193
Authors:
LOYA S
BAKHANASHVILI M
TAL R
HUGHES SH
BOYER PL
HIZI A
Citation: S. Loya et al., ENZYMATIC-PROPERTIES OF 2 MUTANTS OF REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (TYROSINE-181 -] ISOLEUCINE AND TYROSINE-188 -] LEUCINE), RESISTANT TO NONNUCLEOSIDE INHIBITORS, AIDS research and human retroviruses, 10(8), 1994, pp. 939-946
Citation: Pl. Boyer et al., SUBUNIT SPECIFICITY OF MUTATIONS THAT CONFER RESISTANCE TO NONNUCLEOSIDE INHIBITORS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE, Antimicrobial agents and chemotherapy, 38(9), 1994, pp. 1909-1914
Authors:
BOYER PL
TANTILLO C
JACOBOMOLINA A
NANNI RG
DING JP
ARNOLD E
HUGHES SH
Citation: Pl. Boyer et al., SENSITIVITY OF WILD-TYPE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE TO DIDEOXYNUCLEOTIDES DEPENDS ON TEMPLATE LENGTH - THE SENSITIVITY OF DRUG-RESISTANT MUTANTS DOES NOT, Proceedings of the National Academy of Sciences of the United Statesof America, 91(11), 1994, pp. 4882-4886
Authors:
TANTILLO C
DING JP
JACOBOMOLINA A
NANNI RG
BOYER PL
HUGHES SH
PAUWELS R
ANDRIES K
JANSSEN PAJ
ARNOLD E
Citation: C. Tantillo et al., LOCATIONS OF ANTI-AIDS DRUG-BINDING SITES AND RESISTANCE MUTATIONS INTHE 3-DIMENSIONAL STRUCTURE OF HIV-1 REVERSE-TRANSCRIPTASE - IMPLICATIONS FOR MECHANISMS OF DRUG-INHIBITION AND RESISTANCE, Journal of Molecular Biology, 243(3), 1994, pp. 369-387
Authors:
BOYER PL
FERRIS AL
CLARK P
WHITMER J
FRANK P
TANTILLO C
ARNOLD E
HUGHES SH
Citation: Pl. Boyer et al., MUTATIONAL ANALYSIS OF THE FINGERS AND PALM SUBDOMAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE, Journal of Molecular Biology, 243(3), 1994, pp. 472-483